Monday, February 09, 2026
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

soberana

Havana, Jul 30 (Prensa Latina) The first 44 adolescents in Camagüey province, who were included in the 'Ismaelillo' clinical trial with Cuba's Abdala vaccine, have already received their second dose, the Genetic Engineering and Biotechnology Center (CIGB) reported on Friday.
Washington, Jul 6 (Prensa Latina) Design, obtaining and preclinical assessment of Cuban anti-Covid Soberana 02 vaccine candidate reached the headlines of the US magazine ACS Chemical Biology, paving the way for other antiviral vaccines.
Havana, Jun 29 (Prensa Latina) Health authorities reported on Tuesday that 1.6 million Cubans have received all three doses of Covid-19 vaccine candidates in the different forms administered in the country.
Mexico, Jun 20 (Prensa Latina) Mexican media on Sunday highlighted the success of Cuba's Covid-19 vaccine candidate Soberana 02, developed by the Finlay Vaccines Institute (IFV) in Havana, with an efficacy higher than what the World Health Organization (WHO) establishes.
Havana, Jun 7 (Prensa Latina) Members of the control group (placebo) of the Phase III clinical trial of Soberana 02 Covid-19 vaccine candidate receive immunization as of Monday, as part of that study starting in March in eight Havana municipalities.
Havana, May 24 (Prensa Latina) People who were given a placebo during phase III of clinical trial on the Cuban vaccine candidates will receive the first dose of Soberana 02, from June 7 to 11, the Finlay Vaccines Institute said on Monday.